Department of Orthopaedics and Traumatology, Kadirli State Hospital, Osmaniye, Turkey.
Department of Orthopaedics and Traumatology, University of Health Sciences, Adana City Training and Research Hospital, Adana, Turkey.
J Orthop Surg Res. 2024 Sep 28;19(1):606. doi: 10.1186/s13018-024-05100-4.
Orthopedic surgeons face challenges regarding perioperative bleeding during the operations of pelvic and acetabular fracture cases. Although the recently popular tranexamic acid (TXA) has proven to be a useful tool, this study primarily aimed to conduct a retrospective comparative analysis of the results of the prophylactic administration of tranexamic acid during open fixation of pelvis and acetabulum fractures, especially regarding operative time and the amount of blood transfused; and in addition, share the results related to other findings including the management of the erythrocyte suspension use and overall cost as secondary aims and thus providing a comprehensive point of view.
The files of patients with pelvis or acetabulum fractures admitted to the Emergency Clinic of the Adana City Training and Research Hospital between January 1, 2020, and December 31, 2023, were analyzed retrospectively. The inclusion criteria were as follows: patients aged 18 years or older who had undergone open reduction for pelvis or acetabulum fractures.
There were 78 files identified for analysis. Among the fractures, 27 were located at the pelvis (34.61%) and 51 at the acetabulum (65.38%). The pelvic fracture cases' age and preoperative hemoglobulin levels were significantly lower (p = 0.019 and p = 0.006, respectively). When all cases were dichotomized into two groups, ones requiring ICU monitoring and the remaining, there were statistically significant differences in terms of the preoperative hemoglobin levels (p = 0.0446), intraoperative bleeding (p = 0.0134), units of erythrocyte suspension used (p = 0.0066), drain output (p = 0.0301), hospitalization duration (p = 0.0008), and the overall cost (p = 0.0002). The comparison regarding TXA use showed that the use of blood products was significantly higher in the pelvic fractures not treated with TXA (6.44 ± 4.42 units, p = 0.0029). The duration of surgery was shorter for pelvic fractures treated with TXA (98.33 ± 21.76 min, p = 0.047).
Among the variables, the amount of intraoperative bleeding emerged as the most correlated element, which strongly suggests that in managing open reduction internal fixation surgeries performed for pelvis and acetabulum fractures, intraoperative bleeding should be considered as the crucial factor. Therefore, the administration of TXA, by effectively reducing the amount of intraoperative bleeding, should be considered as an essential tool for orthopedic surgeons.
骨科医生在骨盆和髋臼骨折手术中面临围手术期出血的挑战。虽然最近流行的氨甲环酸(TXA)已被证明是一种有用的工具,但本研究主要旨在对骨盆和髋臼骨折切开固定术中预防性使用氨甲环酸的结果进行回顾性比较分析,特别是手术时间和输血量;此外,作为次要目的,分享与红细胞悬液使用和总体成本相关的结果,从而提供全面的观点。
回顾性分析 2020 年 1 月 1 日至 2023 年 12 月 31 日期间入住阿达纳市培训和研究医院急诊诊所的骨盆或髋臼骨折患者的病历。纳入标准为:年龄在 18 岁或以上,接受骨盆或髋臼骨折切开复位的患者。
共分析了 78 份病历。其中,骨盆骨折 27 例(34.61%),髋臼骨折 51 例(65.38%)。骨盆骨折患者的年龄和术前血红蛋白水平明显较低(p=0.019 和 p=0.006)。当所有病例分为两组,即需要 ICU 监测的病例和其余病例时,在术前血红蛋白水平(p=0.0446)、术中出血量(p=0.0134)、红细胞悬液使用单位(p=0.0066)、引流液量(p=0.0301)、住院时间(p=0.0008)和总体成本(p=0.0002)方面存在统计学差异。关于 TXA 使用的比较表明,未使用 TXA 治疗的骨盆骨折患者使用血液制品的比例明显更高(6.44±4.42 单位,p=0.0029)。使用 TXA 治疗的骨盆骨折手术时间更短(98.33±21.76 分钟,p=0.047)。
在这些变量中,术中出血量是最相关的因素,这强烈表明,在管理骨盆和髋臼骨折切开复位内固定手术时,术中出血应被视为关键因素。因此,通过有效减少术中出血量,应将 TXA 的使用视为骨科医生的重要工具。